nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrazinamide—AOX1—Methotrexate—ankylosing spondylitis	0.535	0.561	CbGbCtD
Pyrazinamide—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.104	0.109	CbGbCtD
Pyrazinamide—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0786	0.0825	CbGbCtD
Pyrazinamide—CYP3A4—Betamethasone—ankylosing spondylitis	0.0675	0.0708	CbGbCtD
Pyrazinamide—CYP3A4—Prednisolone—ankylosing spondylitis	0.0666	0.0698	CbGbCtD
Pyrazinamide—CYP3A4—Prednisone—ankylosing spondylitis	0.0629	0.066	CbGbCtD
Pyrazinamide—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0392	0.0412	CbGbCtD
Pyrazinamide—Peptic ulcer—Prednisolone—ankylosing spondylitis	0.00151	0.0321	CcSEcCtD
Pyrazinamide—Hepatomegaly—Prednisolone—ankylosing spondylitis	0.00143	0.0303	CcSEcCtD
Pyrazinamide—Peptic ulcer—Triamcinolone—ankylosing spondylitis	0.00139	0.0296	CcSEcCtD
Pyrazinamide—Peptic ulcer—Methylprednisolone—ankylosing spondylitis	0.00139	0.0295	CcSEcCtD
Pyrazinamide—Hepatomegaly—Triamcinolone—ankylosing spondylitis	0.00131	0.0279	CcSEcCtD
Pyrazinamide—Hepatomegaly—Methylprednisolone—ankylosing spondylitis	0.00131	0.0278	CcSEcCtD
Pyrazinamide—Peptic ulcer—Dexamethasone—ankylosing spondylitis	0.00126	0.0268	CcSEcCtD
Pyrazinamide—Peptic ulcer—Betamethasone—ankylosing spondylitis	0.00126	0.0268	CcSEcCtD
Pyrazinamide—Hepatomegaly—Betamethasone—ankylosing spondylitis	0.00119	0.0253	CcSEcCtD
Pyrazinamide—Hepatomegaly—Dexamethasone—ankylosing spondylitis	0.00119	0.0253	CcSEcCtD
Pyrazinamide—Peptic ulcer—Prednisone—ankylosing spondylitis	0.0011	0.0234	CcSEcCtD
Pyrazinamide—Hepatomegaly—Prednisone—ankylosing spondylitis	0.00104	0.0221	CcSEcCtD
Pyrazinamide—Hepatotoxicity—Methotrexate—ankylosing spondylitis	0.000794	0.0169	CcSEcCtD
Pyrazinamide—Hyperuricaemia—Methotrexate—ankylosing spondylitis	0.000661	0.0141	CcSEcCtD
Pyrazinamide—Blood uric acid increased—Methotrexate—ankylosing spondylitis	0.000625	0.0133	CcSEcCtD
Pyrazinamide—Photosensitivity—Methotrexate—ankylosing spondylitis	0.000507	0.0108	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00041	0.00871	CcSEcCtD
Pyrazinamide—Malaise—Prednisolone—ankylosing spondylitis	0.000398	0.00847	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000377	0.00801	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000376	0.00799	CcSEcCtD
Pyrazinamide—Discomfort—Prednisolone—ankylosing spondylitis	0.000371	0.0079	CcSEcCtD
Pyrazinamide—Malaise—Triamcinolone—ankylosing spondylitis	0.000366	0.00779	CcSEcCtD
Pyrazinamide—Malaise—Methylprednisolone—ankylosing spondylitis	0.000365	0.00777	CcSEcCtD
Pyrazinamide—Dysuria—Methotrexate—ankylosing spondylitis	0.00036	0.00765	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000351	0.00747	CcSEcCtD
Pyrazinamide—Myalgia—Triamcinolone—ankylosing spondylitis	0.000346	0.00735	CcSEcCtD
Pyrazinamide—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000345	0.00734	CcSEcCtD
Pyrazinamide—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000345	0.00734	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000342	0.00727	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000342	0.00727	CcSEcCtD
Pyrazinamide—Discomfort—Triamcinolone—ankylosing spondylitis	0.000341	0.00726	CcSEcCtD
Pyrazinamide—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000341	0.00725	CcSEcCtD
Pyrazinamide—Malaise—Dexamethasone—ankylosing spondylitis	0.000332	0.00707	CcSEcCtD
Pyrazinamide—Malaise—Betamethasone—ankylosing spondylitis	0.000332	0.00707	CcSEcCtD
Pyrazinamide—Myalgia—Dexamethasone—ankylosing spondylitis	0.000314	0.00667	CcSEcCtD
Pyrazinamide—Myalgia—Betamethasone—ankylosing spondylitis	0.000314	0.00667	CcSEcCtD
Pyrazinamide—Discomfort—Dexamethasone—ankylosing spondylitis	0.00031	0.00659	CcSEcCtD
Pyrazinamide—Discomfort—Betamethasone—ankylosing spondylitis	0.00031	0.00659	CcSEcCtD
Pyrazinamide—Hepatitis—Methotrexate—ankylosing spondylitis	0.000308	0.00655	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000302	0.00642	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000301	0.00641	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000298	0.00633	CcSEcCtD
Pyrazinamide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000297	0.00632	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000294	0.00626	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000294	0.00626	CcSEcCtD
Pyrazinamide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000292	0.0062	CcSEcCtD
Pyrazinamide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000291	0.00619	CcSEcCtD
Pyrazinamide—Malaise—Prednisone—ankylosing spondylitis	0.000289	0.00615	CcSEcCtD
Pyrazinamide—Anorexia—Betamethasone—ankylosing spondylitis	0.000287	0.0061	CcSEcCtD
Pyrazinamide—Anorexia—Dexamethasone—ankylosing spondylitis	0.000287	0.0061	CcSEcCtD
Pyrazinamide—Urticaria—Prednisolone—ankylosing spondylitis	0.000286	0.00609	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000274	0.00583	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000274	0.00583	CcSEcCtD
Pyrazinamide—Arthralgia—Prednisone—ankylosing spondylitis	0.000273	0.00581	CcSEcCtD
Pyrazinamide—Myalgia—Prednisone—ankylosing spondylitis	0.000273	0.00581	CcSEcCtD
Pyrazinamide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000273	0.00581	CcSEcCtD
Pyrazinamide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000272	0.00579	CcSEcCtD
Pyrazinamide—Discomfort—Prednisone—ankylosing spondylitis	0.00027	0.00574	CcSEcCtD
Pyrazinamide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000265	0.00565	CcSEcCtD
Pyrazinamide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000265	0.00563	CcSEcCtD
Pyrazinamide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000265	0.00563	CcSEcCtD
Pyrazinamide—Urticaria—Triamcinolone—ankylosing spondylitis	0.000263	0.0056	CcSEcCtD
Pyrazinamide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000263	0.00559	CcSEcCtD
Pyrazinamide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000262	0.00557	CcSEcCtD
Pyrazinamide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000261	0.00556	CcSEcCtD
Pyrazinamide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000261	0.00556	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00026	0.00552	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00026	0.00552	CcSEcCtD
Pyrazinamide—Anorexia—Prednisone—ankylosing spondylitis	0.00025	0.00531	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000249	0.00529	CcSEcCtD
Pyrazinamide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000248	0.00527	CcSEcCtD
Pyrazinamide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000248	0.00527	CcSEcCtD
Pyrazinamide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000244	0.00519	CcSEcCtD
Pyrazinamide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000244	0.00518	CcSEcCtD
Pyrazinamide—Malaise—Methotrexate—ankylosing spondylitis	0.000242	0.00514	CcSEcCtD
Pyrazinamide—Urticaria—Dexamethasone—ankylosing spondylitis	0.000239	0.00508	CcSEcCtD
Pyrazinamide—Urticaria—Betamethasone—ankylosing spondylitis	0.000239	0.00508	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000239	0.00507	CcSEcCtD
Pyrazinamide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000238	0.00506	CcSEcCtD
Pyrazinamide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000238	0.00506	CcSEcCtD
Pyrazinamide—Pruritus—Triamcinolone—ankylosing spondylitis	0.000234	0.00499	CcSEcCtD
Pyrazinamide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000234	0.00498	CcSEcCtD
Pyrazinamide—Dyspepsia—Prednisone—ankylosing spondylitis	0.00023	0.0049	CcSEcCtD
Pyrazinamide—Arthralgia—Methotrexate—ankylosing spondylitis	0.000228	0.00486	CcSEcCtD
Pyrazinamide—Myalgia—Methotrexate—ankylosing spondylitis	0.000228	0.00486	CcSEcCtD
Pyrazinamide—Decreased appetite—Prednisone—ankylosing spondylitis	0.000228	0.00484	CcSEcCtD
Pyrazinamide—Rash—Prednisolone—ankylosing spondylitis	0.000227	0.00483	CcSEcCtD
Pyrazinamide—Dermatitis—Prednisolone—ankylosing spondylitis	0.000227	0.00483	CcSEcCtD
Pyrazinamide—Discomfort—Methotrexate—ankylosing spondylitis	0.000226	0.0048	CcSEcCtD
Pyrazinamide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000216	0.00459	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000214	0.00456	CcSEcCtD
Pyrazinamide—Nausea—Prednisolone—ankylosing spondylitis	0.000214	0.00455	CcSEcCtD
Pyrazinamide—Pruritus—Betamethasone—ankylosing spondylitis	0.000213	0.00452	CcSEcCtD
Pyrazinamide—Pruritus—Dexamethasone—ankylosing spondylitis	0.000213	0.00452	CcSEcCtD
Pyrazinamide—Vomiting—Triamcinolone—ankylosing spondylitis	0.000211	0.00448	CcSEcCtD
Pyrazinamide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00021	0.00447	CcSEcCtD
Pyrazinamide—Rash—Triamcinolone—ankylosing spondylitis	0.000209	0.00444	CcSEcCtD
Pyrazinamide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000209	0.00444	CcSEcCtD
Pyrazinamide—Anorexia—Methotrexate—ankylosing spondylitis	0.000209	0.00444	CcSEcCtD
Pyrazinamide—Rash—Methylprednisolone—ankylosing spondylitis	0.000208	0.00443	CcSEcCtD
Pyrazinamide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000208	0.00443	CcSEcCtD
Pyrazinamide—Urticaria—Prednisone—ankylosing spondylitis	0.000208	0.00442	CcSEcCtD
Pyrazinamide—Body temperature increased—Prednisone—ankylosing spondylitis	0.000207	0.0044	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000199	0.00424	CcSEcCtD
Pyrazinamide—Nausea—Triamcinolone—ankylosing spondylitis	0.000197	0.00419	CcSEcCtD
Pyrazinamide—Nausea—Methylprednisolone—ankylosing spondylitis	0.000196	0.00418	CcSEcCtD
Pyrazinamide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000193	0.0041	CcSEcCtD
Pyrazinamide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000193	0.0041	CcSEcCtD
Pyrazinamide—Vomiting—Betamethasone—ankylosing spondylitis	0.000191	0.00407	CcSEcCtD
Pyrazinamide—Vomiting—Dexamethasone—ankylosing spondylitis	0.000191	0.00407	CcSEcCtD
Pyrazinamide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00019	0.00405	CcSEcCtD
Pyrazinamide—Rash—Betamethasone—ankylosing spondylitis	0.00019	0.00403	CcSEcCtD
Pyrazinamide—Rash—Dexamethasone—ankylosing spondylitis	0.00019	0.00403	CcSEcCtD
Pyrazinamide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000189	0.00403	CcSEcCtD
Pyrazinamide—Dermatitis—Betamethasone—ankylosing spondylitis	0.000189	0.00403	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000189	0.00402	CcSEcCtD
Pyrazinamide—Pruritus—Prednisone—ankylosing spondylitis	0.000185	0.00394	CcSEcCtD
Pyrazinamide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00018	0.00384	CcSEcCtD
Pyrazinamide—Nausea—Dexamethasone—ankylosing spondylitis	0.000179	0.0038	CcSEcCtD
Pyrazinamide—Nausea—Betamethasone—ankylosing spondylitis	0.000179	0.0038	CcSEcCtD
Pyrazinamide—Urticaria—Methotrexate—ankylosing spondylitis	0.000174	0.0037	CcSEcCtD
Pyrazinamide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000173	0.00368	CcSEcCtD
Pyrazinamide—Vomiting—Prednisone—ankylosing spondylitis	0.000166	0.00354	CcSEcCtD
Pyrazinamide—Rash—Prednisone—ankylosing spondylitis	0.000165	0.00351	CcSEcCtD
Pyrazinamide—Dermatitis—Prednisone—ankylosing spondylitis	0.000165	0.00351	CcSEcCtD
Pyrazinamide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000161	0.00343	CcSEcCtD
Pyrazinamide—Nausea—Prednisone—ankylosing spondylitis	0.000156	0.00331	CcSEcCtD
Pyrazinamide—Pruritus—Methotrexate—ankylosing spondylitis	0.000155	0.00329	CcSEcCtD
Pyrazinamide—Vomiting—Methotrexate—ankylosing spondylitis	0.000139	0.00296	CcSEcCtD
Pyrazinamide—Rash—Methotrexate—ankylosing spondylitis	0.000138	0.00293	CcSEcCtD
Pyrazinamide—Dermatitis—Methotrexate—ankylosing spondylitis	0.000138	0.00293	CcSEcCtD
Pyrazinamide—Nausea—Methotrexate—ankylosing spondylitis	0.00013	0.00276	CcSEcCtD
